1David A. Ehrmann MD. Polycystic ovary Syndrome. N Engl J Me 2005; 352:1223 -1236.
2Kchua W, JuanL, John X, ct al. Psychological characteristics and marital quality of infertile woman registered for in vitro fertilization iniracytoplasmic sperm injection in China. Fertil Steril 2007; 87 : 792 -798.
3Jing Z, Liang - Zhi X, Tai - Xiang W, et al. The effects of Diane - 35 and mefformin in treatment of polycystic ovary syndrome: an updated systematic review. Gynecol Endocdnol 2008 ; 24:590 - 600.
4Harbomc L, Fleming R, Lyall H, et al. Meffonnin or antiandrogen in the treatment of hirsufism in polycystic ovary syndrome. J Clin Endocrinol Mctab 2003; 88:4116 -4123.
5Diamanti- Kandarakis E, Christakou CD, Kandaraki E, et al. Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome. EurJ Endocrino 2010; 162:193 -212.
6Palomba S, Falbo A, Russo T, et al. Role of mefformin in patients with polycystic ovary syndrome: the state of the art. Minerva Ginecol 2008 ; 60:77 - 82.
7Trolle B, Flyvbjcrg A, Kesmodcl U, et al. Efficacy of metform in obese and non - obese Women With polycystic ovary syndrome: randomized, double - blinded, Placebo - controlled cross - o- ver triM. Hum Repord 2007; 22(11) : 2967 -2973.
8Tang T, Lord JM, Norman R J, et al. Insulin - semsitising drugs ( metformin, rosiglitazone, pioglitazone, D - chiro - inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfcrtility. Cochrane Database Syst Rev 2009; (3) :CD003053.
10Casper RF. Letrozole: ovulation or superovulation? Fcrtil Steril 2003; 80:1335-1337.
二级参考文献15
1Michael J,Sloweym D, Concord NC. Polycysic ovary syndrom: New perspective on old promble? Southern Medical Journal,2001,94:190-196.
2van Dam EW, Roelfsema F , Veldhuisj D , et al. Increase in daily LH secretion in response to short-term calorie restriction in obese women with PCOS. Am J Physiol Endocrinol Metab,2002,282:865-872.
3Ajossa S ,Guerriero S ,Paolelti AM,et al. The antiandrogenic effect of fluta mide improves uterine perfusion in women with polycystic ovarian syndrome. Fertil Steril, 2002,77:1136-1140.
4Diamanti-Kandarakis E, Spina G, Kouli C, et al. Imcreased endothelin- I levels in women with polycystic ovary syndrome and the beneficial effect of moformin therapy. J Clin Endocrinol Metab, 2001,86:4666-4673.
5Vandemolen DT, Ratts VS, EvansWS, et al. Metformin increases the ovulatory rate and pregnancy rate with clomiphene citrate in patients with poly cystic ovary syndrome who are resistant to clomiphene citrate alone. Fetil Steril, 2001, 75:310-315.
6Jakubowicz DJ,Iuorno MJ,Jakubowicz S, et al. Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J Clin Endocrinol Metab, 2002, 87 : 524-529.
7Glueck CA, Goldenberg N, Wang P, et 81. Mefformin during pregnancy reduces insulin, resistance, insulin secretion, weight, testosterone and development of gestationnal diabetes: prospective longitudinal assessment of women with polycystic ovary syndrome from preconeeption throughout pregnancy. Hum Rep rod, 2004, 19: 510-521.
8Barbieri RL. Meformin for the treatment of polycyctic ovary syndrome. Obstet Gynecol, 2003, 101:785-793. Review.
9TanWC, Yap C, Tan AS. Clinical managment of PCOS. Acta Obstet Gynecol Scand,2001,80:689 - 696.
10Fulghesu AM, Ciampelli M, Muzj G, et al. N-acetyl-cysteine treatment improves insuline sensitivity in women with polycystic ovary syndrome. Fertil Steril , 2002 , 77:1128-1135.
1JING Z, LIANG ZX, TAI XW, et al. The effects of Diane-35 andm etform in intreatment of polycystic ovary syndrom e: an updated system at iereview[J].Gynecol Endocrinol, 2008,24: 590-600.
